Chemplast Sanmar share price goes up after redeeming entire outstanding NCDs worth Rs 1238.25 cr

Chemplast Sanmar share price goes up after redeeming entire outstanding NCDs worth Rs 1238.25 cr

FPJ Web DeskUpdated: Thursday, September 02, 2021, 01:14 PM IST
article-image
At 1.10 PM, Chemplast was trading at Rs 612.70 per piece up 2.14 percent on Sensex | Logo

Chemplast Sanmar Limited announced today that it has redeemed, on 31st August 2021, the entire outstanding NCDs that were issued in December 2019 by the Company.

The redemption of these NCDs amounting to Rs.1238.25 crores, which was part of the Objects of the primary issue, was made using the net proceeds of fresh issue of equity shares of the Company (IPO) made in August 2021.

The company further announced that, using the net proceeds of the Offer for Sale, received by the Selling Shareholders Sanmar Holdings Limited and SESL, the term loan availed by SESL from HDFC Limited has been fully repaid.

Consequently, the security in respect of this loan, including the pledge over the equity shares of CCVL, the wholly owned subsidiary of Chemplast, has been fully released on 31st August 2021 by the Security Trustee.

With this, there is no pledge over the shares of CCVL held by the Company and the shares of Chemplast Sanmar Ltd held by the promoters.

At 1.10 PM, Chemplast was trading at Rs 612.70 per piece up 2.14 percent on Sensex. The stock has touched a new 52-week high of Rs 620 per piece earlier today.

RECENT STORIES

FLY91 Launches Daily Kochi–Agatti Flights, Announces Expansion To 7 New Regional Stations
FLY91 Launches Daily Kochi–Agatti Flights, Announces Expansion To 7 New Regional Stations
Gold Breaches ₹1.5 Lakh Per 10 Grams Mark; Silver Surges To Record ₹3.23 Lakh Per Kg
Gold Breaches ₹1.5 Lakh Per 10 Grams Mark; Silver Surges To Record ₹3.23 Lakh Per Kg
Investors’ Wealth Erodes By ₹9.86 Lakh Crore As Stock Markets Tumble
Investors’ Wealth Erodes By ₹9.86 Lakh Crore As Stock Markets Tumble
Canada–China Trade Deal Ill-Timed And One-Sided Amid Unresolved Disputes: Report
Canada–China Trade Deal Ill-Timed And One-Sided Amid Unresolved Disputes: Report
Concept Medical Launches Global Trial On Next-Gen Drug-Eluting Stent
Concept Medical Launches Global Trial On Next-Gen Drug-Eluting Stent